As China's new drug R&D enters the 'deep waters' of homogeneous competition, the path for followers has become increasingly ...

Insilico Medicine ('Insilico', 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence ...

Syngene collaborates with Johns Hopkins University to accelerate early-stage drug discovery programs and platform technologies.

For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial ...

Synthace, the leader in software and services for assay development, today announced a collaboration with Charles River Laboratories International, Inc. (Charles River), a leading global drug ...

Takeda has joined forces with Iambic Therapeutics on a multiyear collaboration to use the US biotech's AI-driven, structure-based drug discovery platform to find new therapies for gastrointestinal and ...

Iambic’s AI-platform includes Enchant, a multimodal transformer model designed to predict both preclinical and clinical endpoints, alongside NeuralPLexer. 1 Enchant recently received Nvidia HGX B200 ...

To become a leader for humane technologies, India will need bold investments, global alliances, and strengthened participant ...

In a separate financing round, Pandorum Technologies announced the close of an $18 million Series B financing to support the ...

Collaboration Combines Assay Development, AI-Driven Biomarker Discovery and Regulated Manufacturing to Advance Innovative Diagnostic Programs SAN DIEGO, CA / ACCESS Newswire / February 10, 2026 / Calb ...

The partnership aims to advance high-priority small molecule programmes using Iambic’s AI models and wet lab capabilities.

Gubra today announced the launch of Gubra Ventures, a new business unit focused on creating independent biotechnology companies from high-quality scientific innovation. Zoë Johnson has been appointed ...